Aether Bio develops machine learning algorithms and proprietary robotic hardware to engineer enzymes for the production of complex biochemical compounds. This technology enables manufacturers to create novel products at significantly reduced costs by efficiently indexing and searching trillions of enzyme sequences.

Applied Intuition provides a unified development platform that enables automotive manufacturers to create, test, and validate advanced driver-assistance systems (ADAS) and automated driving (AD) technologies at scale. This platform reduces development cycles and enhances safety by utilizing simulation and validation tools to identify issues early in the process, ensuring compliance with safety standards.

Arda Therapeutics develops therapies aimed at eliminating pathogenic cells that drive chronic diseases. The company utilizes single-cell data analysis to precisely identify and characterize these target cells. This approach informs the design of specific therapies engineered to selectively eliminate only the disease-driving cell populations.

Bioptimus is developing a universal AI foundation model specifically for biological research, enabling researchers to leverage large-scale data analysis and predictive modeling. This technology addresses the challenge of slow and fragmented discovery processes in biomedicine by providing a cohesive platform for accelerating insights and innovations.

Cadence OTC is developing a pathway for over-the-counter access to oral contraceptives and emergency contraceptives, eliminating the need for prescriptions and insurance. By placing these products in convenience stores, particularly in healthcare deserts, the company aims to enhance accessibility to safe and affordable contraceptive options for all individuals.

Cambrian Bio is a clinical-stage drug development company focused on creating therapeutics that target the biological mechanisms of aging to prevent chronic diseases. By collaborating with leading scientists, Cambrian aims to develop effective and safe therapies that extend healthspan and improve patient outcomes.

Provides a comprehensive suite of web3 development tools and infrastructure, including the MetaMask wallet, Infura API, and Linea zkEVM rollup, enabling developers to build, scale, and secure decentralized applications. This platform streamlines blockchain integration, reduces transaction costs, and supports high-throughput environments while ensuring compatibility with Ethereum's security and ecosystem.

Deep Genomics utilizes a proprietary AI platform to analyze complex RNA biology data, identifying novel therapeutic targets for genetic conditions. By streamlining the drug discovery process, the company aims to develop RNA therapies that can precisely target genetic causes, significantly reducing the time and cost associated with traditional methods.

Griffin provides a banking-as-a-service platform that enables companies to integrate financial services directly into their products through a simple API. This solution addresses the complexities of regulatory compliance and infrastructure management, allowing businesses to enhance customer engagement and streamline financial operations.

The startup develops deterministic single-core streaming architectures that predict performance and compute time for various workloads. This technology enhances computing speed, quality, and energy efficiency in artificial intelligence and quality-performance computing applications.

Halcyon is a cyber resilience platform that employs a ransomware prevention engine and data exfiltration prevention (DXP) technology to neutralize ransomware threats in real time. By intercepting encryption keys and automating decryption, Halcyon ensures zero ransoms paid and minimizes recovery time to hours, effectively protecting businesses from the financial and operational impacts of ransomware attacks.

Owkin utilizes AI and multimodal patient data to identify biomarkers and match patient subpopulations with targeted drug candidates, enhancing the precision of drug discovery and development. This approach accelerates clinical trials and improves diagnostic accuracy, ultimately aiming to deliver the right treatment to each patient.

Revolut is a financial technology platform that provides digital banking services, enabling users to conduct money transfers, manage foreign exchange, and analyze spending through a unified mobile application. This service addresses the inefficiencies and high costs associated with traditional banking and currency exchange, offering users real-time financial insights and lower transaction fees.

Rippling provides a unified workforce management system integrating HR, IT, and Finance functions onto a single platform. This platform enables organizations to automate workflows, manage global payroll, control IT access, and streamline spend management. By connecting core business data, the system delivers deeper insights and enforces consistent policies across all departments.

SpaceX designs and manufactures reusable rockets to significantly lower the costs of space travel. By enabling multiple launches with the same hardware, the company addresses the high expenses associated with traditional single-use launch systems.

Stairwell provides an Automated Threat Detection and Response platform that enables organizations to search their environments for malware across all time and file variants, delivering definitive yes/no answers on past infections. This technology enhances the efficiency of existing security teams by streamlining workflows and significantly reducing the time spent on threat investigations.